Currently accepted at: JMIR Public Health and Surveillance
Date Submitted: Oct 21, 2025
Date Accepted: Apr 27, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/86209
The final accepted version (not copyedited yet) is in this tab.
Observations from the application of a multimodal data approach for the examination of the 2024-2025 Highly Pathogenic Avian Influenza outbreak in the United States: Descriptive Study
ABSTRACT
Background:
Highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b, a globally predominant strain, was introduced into poultry in the United States (US) in 2022 via spillover from wild birds and has since been regularly reported, posing ongoing risks to animal and human health. In 2024, the US reported the first known HPAI A(H5N1) clade 2.3.4.4b infection in dairy cattle, rapidly evolving into a multispecies outbreak among cattle and poultry with spillover into humans. Publicly available data remained siloed and fragmented, implicating timely response. Innovative multimodal surveillance methods can enhance situational awareness through comprehensive, standardized data collection, integration, and visualization.
Objective:
This study aimed to describe observations from the application of enhanced surveillance methods that collect, integrate, and visualize multimodal data for real-time tracking of the 2024-2025 HPAI A(H5) outbreak in the US as an innovative, transparent, repeatable, and scalable approach for open source public health surveillance.
Methods:
Global.health conducted real-time, multimodal surveillance on the US 2024-2025 HPAI A(H5) outbreak using publicly available data for human cases (Centers for Disease Control and Prevention), animal outbreaks (United States Department of Agriculture), wastewater monitoring (WastewaterSCAN), genomic data (public genomic databases), research updates (scholarly communication), and policy changes and response measures (media and government) for the study period from February 1, 2024 through February 28, 2025. This digital data stream was used to create outbreak resources—an epidemiological linelist, event timeline, and interactive map—using a One Health framework to track emerging hotspots.
Results:
Global.health curated seventy confirmed human HPAI A(H5) cases across 13 states in a linelist, with exposure for nearly all (92.9%) cases associated with commercial agriculture and related operations. We curated 682 timeline entries across six distinct categories: human, cattle, response (e.g., research, policy changes, and public health guidance), birds, genome, wastewater, and mammals. The map integrated human cases (n=70) and animal outbreaks (commercial cattle, n=977; commercial poultry, n=325) into a single view. California was identified as the outbreak epicenter with high numbers of human cases (n= 38, 54.3%), commercial cattle (n=748, 76.6%) and commercial poultry outbreaks (n=66, 20.3%) during the study period. Wastewater surveillance detected the virus in California, with an unknown source at least 81 days before the first confirmed commercial dairy cattle case.
Conclusions:
Global.health’s approach for integrating traditional and non-traditional public health surveillance data within a One Health framework enhanced early situational awareness during the US 2024-2025 HPAI A(H5) outbreak, creating open access to resources that improve contextual understanding of the scope and evolution of this emerging zoonotic event. Further research should seek to understand the full potential of multimodal data in outbreak surveillance.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.